Biosimilar Newsletter Archive

1. 04.19.18 -- Does The U.S. Biosimilar Space Have A Case Of “Progressophobia?”
   4/19/2018
   04/19/18 Biosimilar Development Newsletter
2. 04.12.18 -- Could This Practice Increase U.S. Biosimilar Use?
   4/12/2018
   04/12/18 Biosimilar Development Newsletter
3. 04.05.18 -- How Biosimilar Companies, Employers Can Collaborate
   4/5/2018
   04/05/18 Biosimilar Development Newsletter
4. 03.29.18 -- The U.K.'s Path Toward Biosimilar Implementation
   3/29/2018
   03/29/18 Biosimilar Development Newsletter
5. 03.28.18 -- Is Your Biologic At Risk For Protein Aggregation?
   3/28/2018
   03/28/18 Biosimilar Development Newsletter
6. 03.27.18 -- Are You Ready For The Future Of Biomanufacturing?
   3/27/2018
   03/27/18 Biosimilar Development Newsletter
7. 03.22.18 -- Could This Stakeholder Lead The Biosimilar Charge?
   3/22/2018
   03/22/18 Biosimilar Development Newsletter
8. 03.15.18 -- U.K. Biosimilar Evolutions Worth Watching
   3/15/2018
   03/15/18 Biosimilar Development Newsletter
9. 03.08.18 -- Responsible Pricing, Patient Programs Biggest Biosimilar Challenges
   3/8/2018
   03/08/18 Biosimilar Development Newsletter
10. 03.01.18 -- Biosimilars: Not "A Stake In The Heart Of Innovation"
    3/1/2018
    03/01/18 Biosimilar Development Newsletter